These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9213289)

  • 1. Aggression and schizophrenia: efficacy of risperidone.
    Buckley PF; Ibrahim ZY; Singer B; Orr B; Donenwirth K; Brar PS
    J Am Acad Psychiatry Law; 1997; 25(2):173-81. PubMed ID: 9213289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone in the management of violent, treatment-resistant schizophrenics hospitalized in a maximum security forensic facility.
    Beck NC; Greenfield SR; Gotham H; Menditto AA; Stuve P; Hemme CA
    J Am Acad Psychiatry Law; 1997; 25(4):461-8. PubMed ID: 9460034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Social cognition and atypical antipsychotic agents in the treatment of persons with schizophrenia: preliminary data from a naturalistic study].
    Mazza M; Tozzini C; Giosué P; De Risio A; Palmucci M; Roncone R; Casacchia M
    Clin Ter; 2003; 154(2):79-83. PubMed ID: 12856365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility.
    Citrome L; Shope CB; Nolan KA; Czobor P; Volavka J
    Int Clin Psychopharmacol; 2007 Nov; 22(6):356-62. PubMed ID: 17917554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone: clinical outcome predictors and cost-effectiveness in a naturalistic setting.
    Finley PR; Sommer BR; Corbitt JL; Brunson GH; Lum BL
    Psychopharmacol Bull; 1998; 34(1):75-81. PubMed ID: 9564202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.
    Lerma-Carrillo I; Molina JD; Cuevas-Durán T; González-Parra S; Blasco-Fontecilla H; Andrade-Rosa C; López-Muñoz F; Alamo C
    Clin Neuropharmacol; 2007; 30(2):114-21. PubMed ID: 17414944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
    Salimi S; Fotouhi A; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Mohammadi MR; Noorbala AA; Ahmadi-Abhari SA; Hajiazim M; Abbasi SH; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):726-32. PubMed ID: 18096287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Initial use of risperidone in the treatment of acutely exacerbated schizophrenic patients--an interim analysis].
    Pajonk FG; Schreiner A; Peters S; Rettig K; Degner D; Rüther E
    Fortschr Neurol Psychiatr; 2003 May; 71(5):249-54. PubMed ID: 12740756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia.
    Nakanishi S; Kunugi H; Murray RM; Nojima S; Ogawa T; Takahashi T
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):751-7. PubMed ID: 17109710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia.
    Kim JH; Kim D; Marder SR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):984-8. PubMed ID: 18262321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone treatment for polydipsia and hyponatremia in schizophrenia: a case report.
    Rao N; Venkatasubramanian G; Korpade V; Behere R; Varambally S; Gangadhar B
    Turk Psikiyatri Derg; 2011; 22(2):123-5. PubMed ID: 21638234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
    Buckley PF
    J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Each of the following statements about the newer medications for schizophrenia, risperidone (risperidol) and clozapine (clozaril), is true, except: Patients receiving risperidone are at risk for agranulocytosis.
    Can Fam Physician; 1995 Oct; 41():1678, 1680. PubMed ID: 8829578
    [No Abstract]   [Full Text] [Related]  

  • 20. Aggresiveness in institutionalised schizophrenic patients and the selection of antipsychotics.
    Ruzić K; Francisković T; Suković Z; Hero ED; Roncević-Grzeta I; Graovac M; Palijan TZ
    Coll Antropol; 2011 Jan; 35 Suppl 1():265-9. PubMed ID: 21648345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.